Yet another successful AGITG Preceptorship in Colorectal Cancer was held on Friday 4th and Saturday 5th December, in Melbourne.

This is the third annual two day learning experience offered by AGITG for 42 trainees, at various stages of their early careers. During this unique learning experience, Preceptors offered methodical reviews of information gained through the  performance of clinical trials, and  delivered expert insights into the development of the current  treatments of colorectal cancer.

AGITG Board Member, Preceptorship Developer and Convenor,  A/Prof Eva Segelov said of the event:

“It is my hope that this course will not only help trainees to become evidence-based practitioners,  but also fan enthusiasm for clinical trials and encourage involvement in the AGITG.”

The  course involved significant pre-work for trainees with on the day presentations and expert commentary  provided by the Preceptors, leading Australian GI oncologists: A/Prof Niall Tebbutt, A/Prof Chris Karapetis, Prof Stephen Clarke, A/Prof Peter Gibbs, A/Prof Joseph McKendrick, A/Prof Jeremy Shapiro and A/Prof Eva Segelov.

The intensive learning experience concluded with a multidisciplinary meeting, including expert input from Melbourne surgeons Peter Carne and Val Usatoff and Radiation Oncologist Ian Porter.

Attendees commented that the Preceptorship was:

“(The) best teaching I’ve ever had”   “A useful mix of didactic teaching and small group sessions”

Demand for a Preceptorship in other tumour sites was high, with several attendees commenting “Would be great to have similar preceptorships in other tumour streams e.g. upper GI”.

The AGITG Preceptorship in Colorectal Cancer is supported by an educational grant by Roche Products Pty Limited.